AstraZeneca

News

CDC backs maternal use of Pfizer’s RSV vaccine

The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect newborns and infants from the virus after an advisor

News

AZ, Daiichi Sankyo cue up TROP2 drug filing in breast cancer

Armed with the first phase 3 data for their TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan as a second-line treatment for breast cancer, AstraZeneca

R&D

Partner Content

3rd ADC Target Selection Summit

Optimizing Target Selection Rationale for ADCs & Novel Format Conjugates

Home

2023 PM Society Digital Awards, OPEN Health takes 3 Golds

Over the course of 14 years, the PM Society Digital Awards have cemented their place as a highlight on the healthcare marketing calendar.

Sales & Marketing

12 Questions with Stefan Woxström

Stefan Woxström leads the Europe and Canada business at AstraZeneca and brings a wealth of experience from 27 years with the organisation, having held a variety of local and regional roles

News

WCLC: Chemo adds efficacy and side effects to AZ's Tagrisso

Giving AstraZeneca's EGFR tyrosine kinase inhibitor (TKI) inhibitor Tagrisso in combination with chemotherapy to patients with EGFR-mutated non-small cell lung cancer (NSC

CDC backs maternal use of Pfizer’s RSV vaccine

AZ, Daiichi Sankyo cue up TROP2 drug filing in breast cancer

3rd ADC Target Selection Summit

2023 PM Society Digital Awards, OPEN Health takes 3 Golds

12 Questions with Stefan Woxström

WCLC: Chemo adds efficacy and side effects to AZ's Tagrisso

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

AstraZeneca

Editor's Picks